Celgene Reports - Industry Research
Reports Featuring Celgene
Anal Cancer Market
The Anal Cancer Market size is estimated at USD 0.91 billion in 2024, and is expected to reach USD 1.26 billion by 2029, growing at a CAGR of 6.60% during the forecast period (2024-2029).
Crohn's Disease Diagnostic and Therapeutic Market
The Crohn's disease diagnostics and therapeutics market is estimated to register a CAGR of 3.1% during the forecast period.
Cutaneous T-cell Lymphoma Market
The Cutaneous T-cell Lymphoma Market is expected to witness a CAGR of 1.8% over the forecast period.
Hemoglobinopathies Treatment Market
The global hemoglobinopathies treatment market was studied and projected to grow with a CAGR of nearly 7% over the forecast period.
Scleroderma Therapeutics Market
The scleroderma therapeutics market is expected to register a CAGR of 5.7% over the forecast period.
Other Reports Covering Celgene
Pharmaceuticals
- Anal Cancer Market
- Asia-Pacific Acute Myeloid Leukemia Treatment Market
- Blood Disorder Therapeutics Market
- Cutaneous T-cell Lymphoma Market
- Global Lenalidomide Market
- Global Psoriasis Drugs Market
- Global Rheumatoid Arthritis Drugs Market
- Hemoglobinopathies Treatment Market
- Kaposi Sarcoma Market
- Latin America Bladder Cancer Therapeutics & Diagnostics Market
- Scleroderma Therapeutics Market
- Unresectable Hepatocellular Carcinoma Market
